A phase I study of biweekly capecitabine and the histone deacetylase inhibitors (HDACi) vorinostat in for advanced breast cancer (BC)

Authors
Category Primary study
JournalJournal of Clinical Oncology
Year 2011
This article has no abstract
Epistemonikos ID: f33da424d28c0c97b8f7eb97a2ebbaad0e7a95ee
First added on: Feb 04, 2025